Peng Liu
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Fudan University · Shanghai Zhongshan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Peng Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07791615 · A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory LymphomaCancer Institute and Hospital, Chinese Academy of Medical Sciences · not yet recruiting · Lymphoma, NK T-Cell Lymphoma · principal investigator
- N/ANCT07663253 · Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma PatientsShanghai Zhongshan Hospital · recruiting · Multiple Myeloma · principal investigator
- Ph2NCT07638683 · A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).Shanghai Zhongshan Hospital · recruiting · Multiple Myeloma, AL Amyloidosis · principal investigator
- Ph2NCT07012980 · Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCLShanghai Zhongshan Hospital · recruiting · Diffuse Large B-Cell Lymphoma · principal investigator
- N/ANCT05965115 · The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE StudyShanghai Zhongshan Hospital · recruiting · Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance · principal investigator
- Ph2NCT05940064 · Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell LymphomaPeng Liu · completed · Diffuse Large B Cell Lymphoma · principal investigator
- Ph2NCT05436223 · Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's LymphomaHrain Biotechnology Co., Ltd. · unknown · B-cell Non-Hodgkin's Lymphoma · principal investigator
- N/ANCT05318391 · Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell LymphomaShanghai Zhongshan Hospital · completed · Lymphoma, Large B-Cell, Diffuse, Gene Expression Profiling · principal investigator
- Ph2NCT05316246 · Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell LymphomaShanghai Zhongshan Hospital · unknown · NK/T Cell Lymphoma Nos · principal investigator
- N/ANCT03963713 · Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic TumorsPeking University Third Hospital · unknown · Radiotherapy, Spine Metastases, Radiosurgery · principal investigator
- Ph1NCT03706547 · Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MMPeng Liu · unknown · Multiple Myeloma in Relapse, Multiple Myeloma Progression · principal investigator
- Ph2NCT03605056 · Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MMPeng Liu · unknown · Multiple Myeloma · principal investigator
- Ph4NCT02406248 · Brilinta Taiwan Post Approval Safety StudyAstraZeneca · completed · Non ST-elevation Myocardial Infarction · principal investigator
- Ph3NCT02082769 · Safety and Efficacy of Oral Febuxostat in Subjects With GoutXijing Hospital · completed · Gout · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 28 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:31 UTC. The ranking covers the 200 most relevant of 737 PubMed records, and a shared surname and initials can bring in a namesake. All 737 on PubMed
- Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.Diabetes Care · 19972,918 citationsRCR 84.9
- 1,815 citationsRCR 48.2
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.Lancet Infect Dis · 2021862 citationsRCR 47.1
- 611 citationsRCR 28.9
- [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].Zhejiang Da Xue Xue Bao Yi Xue Ban · 2020446 citationsRCR 24.1
- Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study.J Am Coll Cardiol · 2008314 citationsRCR 7.5
- Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure.Am J Respir Crit Care Med · 1995272 citationsRCR 9.7
- 248 citationsRCR 8.1
- 194 citationsRCR 24.8
- Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.BMC Med · 2012178 citationsRCR 5.5